Stocks To Buy Forum

Stocks to Buy based on the Best Stock Market Research

Pfizer has the only FDA-approved drug in a class called CCR5 antagonists. A "cure for HIV" will most likely focus on CCR5, top scientist say.

 

If not by Pfizer's maraviroc, then a next-generation version of it could be part of the long-awaited cure. This isn't like fusion energy, where the breakthrough is always 30 years away. In this case, a conservative bet is 10 years. Actually, a cure for HIV has been demonstrated in one patient, which amounts to a proof of concept.

 

Some background:

 

Mutations in human genes cause muscular dystrophy, but a mutation in the CCR5 gene has a huge health benefit: people with it are almost completely resistant to HIV infection. Since that discovery was made in 1996, Pfizer and other pharmaceutical companies have become focused on developing a treatment that mimics the effects of a CCR5 mutation.

 

Here is a summary I wrote that describes the race for a cure for HIV -- http://bit.ly/OGbWQn

Tags: AIDS, Pfizer, biotechnology, pharmaceuticals

Views: 167

Attachments:

Reply to This

Subscription Service

Top Stocks to Buy on Dips: 2014

Yelp (YELP)
Twitter (TWTR)
Noodles & Co (NDLS)
Facebook (FB)
Tesla (TSLA)
Zillow (Z)
SolarCity (SCTY)
Small Cap 3x Bull (TNA)

 

Twitter - Free Stock Alerts

Like Us on Facebook

Stock Alerts

- Subscribe Via RSS Feed or - Subscribe to Stocks To Buy by Email



© 2014   Created by Stocks To Buy.

Badges  |  Report an Issue  |  Terms of Service